Singapore markets open in 3 hours 4 minutes
Straits Times Index
3,201.89 +10.73 (+0.34%) S&P 500
4,088.85 +80.84 (+2.02%) Dow
32,654.59 +431.17 (+1.34%) Nasdaq
11,984.52 +321.73 (+2.76%) BTC-USD
30,449.95 +422.52 (+1.41%) CMC Crypto 200
677.94 +435.26 (+179.36%)
Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 63.10B |
| Enterprise value | 55.73B |
| Trailing P/E | 26.03 |
| Forward P/E | 17.15 |
| PEG Ratio (5 yr expected) | 0.36 |
| Price/sales (ttm) | 8.04 |
| Price/book (mrq) | 5.79 |
| Enterprise value/revenue | 7.01 |
| Enterprise value/EBITDA | 18.23 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.61 |
| 52-week change 3 | 18.41% |
| S&P500 52-week change 3 | -2.90% |
| 52-week high 3 | 292.75 |
| 52-week low 3 | 176.36 |
| 50-day moving average 3 | 260.36 |
| 200-day moving average 3 | 218.84 |
Share statistics
| Avg vol (3-month) 3 | 1.65M |
| Avg vol (10-day) 3 | 1.8M |
| Shares outstanding 5 | 255.76M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 253.94M |
| % held by insiders 1 | 0.27% |
| % held by institutions 1 | 94.48% |
| Shares short (28 Apr 2022) 4 | 3.41M |
| Short ratio (28 Apr 2022) 4 | 1.98 |
| Short % of float (28 Apr 2022) 4 | 1.34% |
| Short % of shares outstanding (28 Apr 2022) 4 | 1.33% |
| Shares short (prior month 30 Mar 2022) 4 | 4.01M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 2:1 |
| Last split date 3 | 23 Aug 2000 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Dec 2021 |
Profitability
| Profit margin | 30.92% |
| Operating margin (ttm) | 36.69% |
Management effectiveness
| Return on assets (ttm) | 13.79% |
| Return on equity (ttm) | 24.93% |
Income statement
| Revenue (ttm) | 7.57B |
| Revenue per share (ttm) | 29.39 |
| Quarterly revenue growth (yoy) | 27.30% |
| Gross profit (ttm) | 3.62B |
| EBITDA | 2.9B |
| Net income avi to common (ttm) | 2.34B |
| Diluted EPS (ttm) | 9.01 |
| Quarterly earnings growth (yoy) | 27.50% |
Balance sheet
| Total cash (mrq) | 7.52B |
| Total cash per share (mrq) | 29.56 |
| Total debt (mrq) | 967.4M |
| Total debt/equity (mrq) | 9.58 |
| Current ratio (mrq) | 4.46 |
| Book value per share (mrq) | 39.69 |
Cash flow statement
| Operating cash flow (ttm) | 2.64B |
| Levered free cash flow (ttm) | 1.71B |
© 2022 Yahoo. All rights reserved.
